Search

Search bills, members, committees and pages...

H.R. 10133

U.S. HouseIn House Committee

Summary

H.R. 10133, the Fair Prescription Pricing Act of 2026, was introduced in the House on Aug 20, 2026 by Rep. Hillary Scholten (D). It was referred to Energy And Commerce, and last saw action on Aug 20, 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


Record

Text

H.R. 10133 has no co-sponsors and has not gone to a roll call.

hb10133/introduced-in-house.txt
119 HR 10133 IH: Fair Prescription Pricing Act of 2026
U.S. House of Representatives
2026-08-20
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 2d Session H. R. 10133 IN THE HOUSE OF REPRESENTATIVES August 20, 2026 Ms. Scholten introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committees on Ways and Means , and Education and Workforce , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to ensure cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug.
1.
Short title
This Act may be cited as the Fair Prescription Pricing Act of 2026 .
2.
Ensuring cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug
(a)
PHSA
Part D of title XXVII of the Public Health Service Act ( 42 U.S.C. 300gg–111 et seq. ) is amended by adding at the end the following new section:
2799A–12.
Limitation on cost sharing for drugs
(a)
In general
For plan years beginning on or after the date of the enactment of this section, a group health plan, and a health insurance issuer offering group or individual health insurance coverage, may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered outpatient drug for which benefits are available under such plan or coverage dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug for the 1-year period ending on the first day of such plan year (as determined using information from the survey described in section 1927(f)(1)(A)(i) of the Social Security Act).
(b)
Clarification on application to pharmacy benefit managers
A group health plan, and a health insurance issuer offering group or individual health insurance coverage, shall ensure that any pharmacy benefit manager providing services under the plan or coverage complies with subsection (a) in the same manner as such subsection applies with respect to such plan or issuer.
(c)
Definitions
In this section:
(1)
Covered outpatient drug
The term covered outpatient drug has the meaning given such term in section 1927(k) of the Social Security Act.
(2)
In-network pharmacy
The term in-network pharmacy means, with respect to a group health plan or group or individual health insurance coverage and a drug, a pharmacy with a contractual relationship in effect for dispensing such drug under such plan or coverage.
.
(b)
ERISA
(1)
In general
Subpart B of part 7 of subtitle B of title I of the Employee Retirement Income Security Act of 1974 ( 29 U.S.C. 1185 et seq. ) is amended by adding at the end the following new section:
727.
Limitation on cost sharing for drugs
(a)
In general
For plan years beginning on or after the date of the enactment of this section, a group health plan, and a health insurance issuer offering group coverage, may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered outpatient drug for which benefits are available under such plan or coverage dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug for the 1-year period ending on the first day of such plan year (as determined using information from the survey described in section 1927(f)(1)(A)(i) of the Social Security Act).
(b)
Clarification on application to pharmacy benefit managers
A group health plan, and a health insurance issuer offering group health insurance coverage, shall ensure that any pharmacy benefit manager providing services under the plan or coverage complies with subsection (a) in the same manner as such subsection applies with respect to such plan or issuer.
(c)
Definitions
In this section:
(1)
Covered outpatient drug
The term covered outpatient drug has the meaning given such term in section 1927(k) of the Social Security Act.
(2)
In-network pharmacy
The term in-network pharmacy means, with respect to a group health plan or group health insurance coverage and a drug, a pharmacy with a contractual relationship in effect for dispensing such drug under such plan or coverage.
.
(2)
Clerical amendment
The table of contents in section 1 of such Act is amended by inserting after the item relating to section 715 the following new item:
Sec. 727. Limitation on cost sharing for drugs.
.
(c)
IRC
(1)
In general
Subchapter B of chapter 100 of the Internal Revenue Code of 1986 is amended by adding at the end the following new section:
9827.
Limitation on cost sharing for drugs
(a)
In general
For plan years beginning on or after the date of the enactment of this section, a group health plan may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered outpatient drug for which benefits are available under such plan dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug for the 1-year period ending on the first day of such plan year (as determined using information from the survey described in section 1927(f)(1)(A)(i) of the Social Security Act).
(b)
Clarification on application to pharmacy benefit managers
A group health plan shall ensure that any pharmacy benefit manager providing services under the plan complies with subsection (a) in the same manner as such subsection applies with respect to such plan.
(c)
Definitions
In this section:
(1)
Covered outpatient drug
The term covered outpatient drug has the meaning given such term in section 1927(k) of the Social Security Act.
(2)
In-network pharmacy
The term in-network pharmacy means, with respect to a group health plan and a drug, a pharmacy with a contractual relationship in effect for dispensing such drug under such plan.
.
(2)
Clerical amendment
The table of sections for such subchapter is amended by adding at the end the following new item:
Sec. 9827. Limitation on cost sharing for drugs.
.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2026-08-20
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to ensure cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug.

Sponsors

Rep. Hillary Scholten (D) sponsors H.R. 10133 alone.

Committees

H.R. 10133 went before 3 committees: Education and Workforce, Ways and Means and Energy and Commerce.

Education and Workforce
Education and Workforce
Referred To · Aug 20, 2026 · 824 Bills
Ways and Means
Ways and Means
Referred To · Aug 20, 2026 · 1,160 Bills
Energy and Commerce
Energy and Commerce
Referred To · Aug 20, 2026 · 1,636 Bills

Actions

H.R. 10133 has taken 2 actions since Aug 20, 2026.

ChamberAction
Aug 20, 2026
House
Introduced in House
Aug 20, 2026
House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Energy and Commerce Committee

Votes

H.R. 10133 has not gone to a roll call.

Titles

H.R. 10133 goes by 3 titles, 1 of them short titles.

  • Fair Prescription Pricing Act of 2026 — Short Title(s) as Introduced
  • Fair Prescription Pricing Act of 2026 — Display Title
  • To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to ensure cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug. — Official Title as Introduced

Classification

The Congressional Research Service files H.R. 10133 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 10133’s is Health.

hr10133/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 10133, as entered in the Congressional Record.

[Congressional Record Volume 172, Number 134 (Thursday, August 20, 2026)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. SCHOLTEN:H.R. 10133.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H5249]

Source: congress.gov · legiscan.com